NLC Funds
Invest in a highly diversified portfolio and generate impact at scale.
NLC funds provide institutional and private investors access to a highly diversified portfolio of impactful healthtech ventures with one single investment, allowing them to spread risk over multiple investments at low transaction costs. Our latest fund, the NLC Health Impact Fund is SDFR9 compliant and currently open to investments.
Our impact
10
Countries our funds are active in
120+
Investments made by our funds
2.4M
Patients impacted
4
Captive funds
SFDR9
Compliant
€40M+
Under management of NLC funds
Open Fund
NLC Health Impact Fund
The NLC Health Impact Fund is NLC’s latest and largest fund. With a total size of €34.4M, it invests in a highly diversified portfolio of 50+ groundbreaking NLC ventures.
Fundraising status
ACTIVELY RAISING
Total size:
€34.4 M
Number of portfolio companies
50+
Geographical Focus:
Europe &US
Examples of ventures in the HIF portfolio
SERDA Therapeutics
SERDA Therapeutics is a leader in developing innovative treatments for severe wound care. With an aging population and increasing diabetes prevalence, effective wound treatment is critical. Traditional debridement methods—surgical, mechanical, and enzymatic—are often painful and inefficient. SERDA’s solution is a hydrogel which offers an enzymatic wound debrider that shows fast speed of debridement, ease of use, high level of stability, and low-moderate irritation potential.
Visit website
Download documents
.webp)
StarTric
StarTric is committed to transforming the treatment of Tricuspid Regurgitation (TR), a severe cardiac condition that affects millions worldwide. StarTric aims to replicate the open-heart surgical Clover technique, very effective but applicable to only a tiny minority of patients, with a minimally invasive device that can avoid the surgical risk and be as effective as the Clover itself.
Visit website
Download documents
open funds
NLC Health Impact Fund
The NLC Health Impact Fund is NLC’s latest and largest fund. With a total size of €34.4M, it invests in a highly diversified portfolio of 50+ groundbreaking NLC ventures.
Fundraising status
ACTIVELY RAISING
Total size:
€34.4 M
Number of portfolio companies
50+
Geographical Focus:
Europe &US
Closed funds
Stepping Stone Fund
The Stepping Stone Fund was set up at the end of 2020 to invest in 40 promising new start-ups all built and supported by NLC.
Fundraising status
Closed in 2021
Number of portfolio companies
40
Investment Phase
Pre-Seed to Series A
Geographical Focus
Europe
Momentum Fund
Momentum was established in 2020 to supply seed capital to 11 transformative NLC ventures.
Fundraising status
Closed in 2020
Number of portfolio companies
11
Investment Phase
Pre-Seed to Seed
Geographical Focus
Europe
Invest in Health ventures
Create a healthier future with us
No items found.
Disclaimer
The Health Impact Fund is accessible to investors residing in all the EU Member States. Investors acquire interests in the Health Impact Fund and not direct ownership in any underlying asset in which the Fund invests. No leverage is used at the fund level.
This webpage is a marketing material which has been prepared by NLC Fund Management B.V. (‘NLC’) with the purpose of sharing relevant information concerning the funds under their management. It does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, which will only be made by means of an information memorandum and/or subscription documents. You may not rely on this webpage as the basis upon which to make an investment decision. This webpage does not purport to be complete on any topic addressed. NLC has not verified or analyzed the information included in this webpage for accuracy or completeness. NLC shall not bear any liability for the information contained in, or any omissions from, this webpage.
This webpage is a marketing material which has been prepared by NLC Fund Management B.V. (‘NLC’) with the purpose of sharing relevant information concerning the funds under their management. It does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, which will only be made by means of an information memorandum and/or subscription documents. You may not rely on this webpage as the basis upon which to make an investment decision. This webpage does not purport to be complete on any topic addressed. NLC has not verified or analyzed the information included in this webpage for accuracy or completeness. NLC shall not bear any liability for the information contained in, or any omissions from, this webpage.